Ms. Kim Rodriguez has over 20 years of commercial and operational leadership roles building standard of care medical technology portfolios, exceptional management teams, demonstrated execution and world-class company cultures.
Most recently Kim served as the President, CEO & co-founder of Acessa Health, that was acquired by Hologic in August of 2020. Previously, she served as Halt Medical’s President & CEO, where she led the transition to sell its assets to Acessa Health. Prior to Acessa and Halt, she was Senior Vice President of the Vascular Intervention business unit at Spectranetics, a publicly-traded cardiovascular company acquired by Royal Philips for $2.2B. Prior to Spectranetics, Kim served in a series of global senior leadership roles across sales, marketing, therapy development and general business management at Johnson & Johnson, Blockade Medical acquired by Balt International, Concentric Medical acquired by Stryker Neurovascular, Guidant Corporation acquired by Abbott Vascular and Microvena acquired by ev3. Over the course of her career in cardiology, radiology, vascular surgery, neurology and women’s health, Kim has been involved in the commercialization of dozens of innovative medtech technologies and M&A transactions. Kim has held the position of Advisor or Independent Board Director at several companies.
Kim received her Executive MBA at the University of Southern California Marshall School of Business and BS in Management from Pepperdine University.